Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roivant
Pharma
Organon pays up to $1.2B to acquire Dermavant and its drug Vtama
With its latest acquisition, women’s health outfit Organon is bringing its dermatology business to the U.S. with a potential blockbuster in tow.
Fraiser Kansteiner
Sep 18, 2024 10:09am
Dermavant's Vtama excels in another trial in atopic dermatitis
Jan 11, 2024 10:46am
With Dermavant's Vtama struggling, Leerink slashes projections
Nov 14, 2023 11:13am
What does Vivek Ramaswamy say for the life sciences brand?
Aug 15, 2023 10:30am
Arbutus, Genevant claim Pfizer patent infringement in new suit
Apr 4, 2023 11:48am
Moderna's motion to dismiss patent suit denied by federal judge
Nov 3, 2022 4:23pm
